SIGA TPOXX: רווח למניה לשנה מתגלגלת

SIGA Technologies, Inc. (SIGA) relies on government contracts for TPOXX, which guarantees a stable cash flow and high margins. The annual change in EPS (TTM) allows for an assessment of the business's actual expansion speed, while the value -99.00 captures the metric level. Prospects are based on the introduction of liquid drug formulations and a monopoly supplier status, providing the company with significant pricing power.
siga.com - פילוחים אנליטיים ומדדי מפתח (SIGA)

This indicator measures the dynamics of the rolling annual earnings per share, allowing for an assessment of net income growth rates relative to the previous period and the impact of operating expenses on margins. By analyzing the relative change in EPS YoY (TTM), an investor determines the investment attractiveness of SIGA Technologies, Inc. (SIGA), considering the high dependence of its returns on the stability of government defense orders for anti-smallpox drugs.